Healthcare -
Biotechnology - NASDAQ - US
$ 1.9
-1.04 %
$ 398 M
Market Cap
-1.23
P/E
ALLO - NET CHANGE IN CASH
Net Change in Cash ALLO - Allogene Therapeutics, Inc.
21.3 M
LAST VALUE
107.64%
2 YEAR CAGR
-25.68%
5 YEAR CAGR
0.00%
10 YEAR CAGR